A study investigating the effect of bendamustine when given along with prednisone and bortezomib on stem cell mobilization and autologous stem cell transplantation in patients with Multiple Myeloma

Trial Profile

A study investigating the effect of bendamustine when given along with prednisone and bortezomib on stem cell mobilization and autologous stem cell transplantation in patients with Multiple Myeloma

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jul 2015

At a glance

  • Drugs Bendamustine (Primary) ; Bortezomib; Prednisone
  • Indications Stem cell mobilisation
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jul 2015 New trial record
    • 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top